Pharmaceutical Raw Material CAS 80241-83-1 Roxithromycin with Best Price

• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >98%
• Model NO.: TGY-068 Roxithromycin
• Product Name: Roxithromycin
• Appearance: White Powder
• CAS No.: 80241-83-1
• Molecular Formula: C41h76n2o15
• Molecular Weight: 514.63
• Assay: 99%
• COA: Available
• Sample: Available
• MOQ: Any Quantitiy
• Service: OEM
• Grade: Pharmaceutical Grade
• Test Method: USP;GMP
• Storage: Cool Dry Area
• Shelf Life: 24 Months Properly
• Certificate: ISO9001:2008
• Transport Package: Boil Bag
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China (Mainland)
• HS Code: 29225090
• Production Capacity: 5000kg/Month

Product Description

Roxithromycin is a semi-synthetic 14 yuan macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, its antibacterial effect in vivo is 1-4 times stronger than that of erythromycin, its effect on Gram-positive bacteria is slightly worse than that of erythromycin, its effect on Legionella pneumophila is stronger than that of erythromycin, and its antimicrobial effect on Chlamydia pneumoniae, Mycoplasma pneumoniae and Ureaplasma urealyticum is similar to or slightly stronger than that of erythromycin. Roxithromycin is a semi-synthetic macrolide antibiotic. This product can penetrate bacterial cell membrane and achieve antibacterial effect by inhibiting the synthesis of bacterial protein.
 

Product Name	Roxithromycin
CAS	80241-83-1
MF	C41H76N2O15
MW	514.63
Purity	99%
Appearance	White or off-white crystalline powder
Usage	cardiotonic. an angiotensin II receptor antagonist. anti-cancer agent
Categorie	Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;INTERMEDIATESOF;Antihypertensive;Imidazoles;(intermediates of telmisartan);Telmisartan;Hypertension;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Other Products;Hypertension.;CARADRIN
Synonyms	TU-199;TELMISARTAN;PRITOR;MICARDIS;BIBR 277; 4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID; 4'-[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID; 3-methoxy-8-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methyl sulfinyl]-2,7,9-triazabicyclo[4.3.0]nona-2,4,8,10-tetraene

Roxithromycin is a semi-synthetic macrolide antibiotic.
Roxithromycin is used to treat respiratory tract,urinary and soft tissue infections.
Roxithromycin is derived from erythromycin,containing the same 14-membered lactone ring.However,an N-oxime side chain is attached to the lactone ring.
Roxithromycin is also currently undergoing clinical trials for the treatment of male-pattern hair loss.

Roxithromycin can be used for skin and soft tissue.
Roxithromycin is used to treat respiratory tract, urinary and soft tissue infections.
Roxithromycin is also currently undergoing clinical trials for the treatment of male-pattern hair loss.